German - Germany Priority Conditions Packet

Price: $19

An education-only research summary, in German, covering the ten main reasons German physicians gave when prescribing cannabis medicines at statutory health insurance expense (BfArM accompanying survey, 2017–2022), grouped into five sections:

- Chronic pain

- Cancer symptoms, nausea and vomiting, anorexia and wasting

- Spasticity and multiple sclerosis, migraine, restless legs syndrome

- Depression and ADHD

- Inflammatory bowel disease

What's inside:

- What published research does and does not show for each condition, with plain evidence-strength labels

- Clinician questions to weigh for every section

- Cautions that apply to all ten: psychosis, cannabis use disorder, hyperemesis, driving, pregnancy and medicine lists

- Why these ten in Germany (BfArM accompanying survey) and what German studies show

- German legal context: the 2017 law, MedCanG (2024), insurance approval under § 31(6) SGB V, the 2026 end of insurance coverage for flowers, and the pending bill

- Patient handoff sheets in German that a clinician may copy for patients

- 72 numbered sources; every PubMed citation checked by PMID in October 2026

14-page PDF. German edition, machine-assisted translation of the English original, which governs. Citations and source titles remain in English.

Auf Deutsch: Forschungsübersicht zu den zehn häufigsten Gründen für Cannabisverordnungen in Deutschland, mit Informationsblättern für Patientinnen und Patienten und rechtlichem Rahmen (MedCanG, § 31 Abs. 6 SGB V, Änderungen 2026). Nur zur Bildung: keine Dosierungen, keine Produktempfehlungen, keine Bewertung von Wechselwirkungen.

Education only. No doses, no product recommendations, no drug-interaction verdicts. Not medical or legal advice.

By Annie Romelfanger, Romelfanger Cannabis Education. romelfangercannabis.com